PMID: 9180835Feb 1, 1997Paper

Predictive factors of local recurrence of in situ intraductal carcinoma. Apropos of 217 cases

Bulletin du cancer
M AbbesM Lallement

Abstract

The authors have reviewed 217 cases of pure intraductal carcinomas with a mean follow-up of 98 months (with 2 deaths out of 31 recurrences from which 35% into adenocarcinomas). The data concerning the diagnosis, the tumor size, the pathological type, the surgical treatment, more of less associated to radiation therapy are detailed. The aim of this work was to give a more reliable way or approaching the recurrence rate (31/217) to be able to apply a more conservative treatment to these cases. The lymph node dissection and removal seams to be useless in the in situ carcinomas. Concerning the tumor size, the local tumors can be treated by conservative surgical procedures and do not get any benefit from radiotherapy. The opposite is true concerning more largely invasive tumor. Concerning the histology, the non-comedocarcinomatous tumors get less benefit from radiotherapy than the comedocarcinomatous type. The study of the tumor limits and the reliquats seem to be useful. The treatment chosen and applied remains the major prognostic element in the probability of recurrence.

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Hinyokika kiyo. Acta urologica Japonica
J WatanabeS Aoshima
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Y ShibamotoM Abe
Journal de gynécologie, obstétrique et biologie de la reproduction
E BarrangerS Uzan
© 2021 Meta ULC. All rights reserved